Transcription of Hepatitis Screening – Commercial Medical Policy
{{id}} {{{paragraph}}}
Example: confidence
Hepatitis Screening – Commercial Medical Policy
Hepatitis Screening Page 1 of 9 UnitedHealthcare Commercial Medical Policy Effective 10/01/2021 Proprietary Information of UnitedHealthcare. Copyright 2021 United HealthCare Services, Inc. UnitedHealthcare Commercial Medica l Policy Hepatitis Screening Policy Number: 2021T0548X Effective Date: October 1, 2021 Instructions for Use Table of Contents Page Coverage Rationale .. 1 Definitions .. 2 Applicable Codes .. 3 Description of Services .. 3 Clinical Evidence .. 4 Food and Drug Administration .. 6 References .. 6 Policy History/Revision Information .. 7 Instructions for Use .. 8 Coverage Rationale Hepatitis C virus (HCV) Screening is proven and medically necessary in adults aged 18 to 79 years whether or not risk factors have been identified. Hepatitis B Screening is proven and medically necessary in individuals with the following indications: Blood transfusion prior to 1992 Birth in or travel to regions with high or moderate prevalence of Hepatitis B virus (HBV) infection Elevated ALT/AST of unknown etiology Clotting-factor disorders, such as hemophilia Exposure to blood or body fluids Donors of blood, plasma, organs, tissue, or semen Following exposure to an individu
Hepatitis B Surface Antigen Test: Also known as HBV Surface Antigen (HBsAg). Hepatitis B antigen is a protein on the surface of hepatitis B virus; it can be detected in high levels in serum during acute or chronic hepatitis B virus infection. The presence of HBsAg indicates that the person is infectious.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: